Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19
Conditions: COVID-19; SARS-CoV2 Interventions: Biological: SAB-185; Other: Normal Saline Sponsors: SAb Biotherapeutics, Inc.; Biomedical Advanced Research and Development Authority; Joint Program Executive Office (JPEO) Chemical, Biological, Radiological, and Nuclear Defense (CBRND) Enabling Biotechnologies (EB) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials